Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

A woman developed skin lesions after PRP injections, possibly linked to COVID-19 infection and vaccination.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.